Enolase 1 Correlated With Cancer Progression and Immune-Infiltrating in Multiple Cancer Types: A Pan-Cancer Analysis

Enolase 1 (ENO1) is an oxidative stress protein expressed in endothelial cells. This study aimed to investigate the correlation of ENO1 with prognosis, tumor stage, and levels of tumor-infiltrating immune cells in multiple cancers. ENO1 expression and its influence on tumor stage and clinical progno...

Full description

Bibliographic Details
Main Authors: Wenhua Xu, Wenna Yang, Chunfeng Wu, Xiaocong Ma, Haoyu Li, Jinghui Zheng
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-02-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2020.593706/full
_version_ 1818915132234792960
author Wenhua Xu
Wenna Yang
Chunfeng Wu
Xiaocong Ma
Haoyu Li
Jinghui Zheng
author_facet Wenhua Xu
Wenna Yang
Chunfeng Wu
Xiaocong Ma
Haoyu Li
Jinghui Zheng
author_sort Wenhua Xu
collection DOAJ
description Enolase 1 (ENO1) is an oxidative stress protein expressed in endothelial cells. This study aimed to investigate the correlation of ENO1 with prognosis, tumor stage, and levels of tumor-infiltrating immune cells in multiple cancers. ENO1 expression and its influence on tumor stage and clinical prognosis were analyzed by UCSC Xena browser, Gene Expression Profiling Interactive Analysis (GEPIA), The Cancer Genome Atlas (TCGA), and GTEx Portal. The ENO1 mutation analysis was performed by cBio Portal, and demonstrated ENO1 mutation (1.8%) did not impact on tumor prognosis. The relationship between ENO1 expression and tumor immunity was analyzed by Tumor Immune Estimation Resource (TIMER) and GEPIA. The potential functions of ENO1 in pathways were investigated by Gene Set Enrichment Analysis. ENO1 expression was significantly different in tumor and corresponding normal tissues. ENO1 expression in multiple tumor tissues correlated with prognosis and stage. ENO1 showed correlation with immune infiltrates including B cells, CD8+ and CD4+ T cells, macrophages, neutrophils, and dendritic cells, and tumor purity. ENO1 was proved to be involved in DNA replication, cell cycle, apoptosis, glycolysis process, and other processes. These findings indicate that ENO1 is a potential prognostic biomarker that correlates with cancer progression immune infiltration.
first_indexed 2024-12-19T23:57:25Z
format Article
id doaj.art-a21db29e1317419b9ba8c1402a137fdd
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-19T23:57:25Z
publishDate 2021-02-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-a21db29e1317419b9ba8c1402a137fdd2022-12-21T20:00:57ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2021-02-011010.3389/fonc.2020.593706593706Enolase 1 Correlated With Cancer Progression and Immune-Infiltrating in Multiple Cancer Types: A Pan-Cancer AnalysisWenhua Xu0Wenna Yang1Chunfeng Wu2Xiaocong Ma3Haoyu Li4Jinghui Zheng5Department of Cardiology, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, ChinaDepartment of Cardiology, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, ChinaDepartment of Cardiology, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, ChinaGraduate School, Guangxi University of Chinese Medicine, Nanning City, ChinaDepartment of Ophthalmology, Jingliang Eye Hospital Affiliated to Guangxi Medical University, The First Affiliated Hospital of Guangxi University of Chinese Medicine, Nanning, ChinaDepartment of Cardiology, Ruikang Hospital Affiliated to Guangxi University of Chinese Medicine, Nanning, ChinaEnolase 1 (ENO1) is an oxidative stress protein expressed in endothelial cells. This study aimed to investigate the correlation of ENO1 with prognosis, tumor stage, and levels of tumor-infiltrating immune cells in multiple cancers. ENO1 expression and its influence on tumor stage and clinical prognosis were analyzed by UCSC Xena browser, Gene Expression Profiling Interactive Analysis (GEPIA), The Cancer Genome Atlas (TCGA), and GTEx Portal. The ENO1 mutation analysis was performed by cBio Portal, and demonstrated ENO1 mutation (1.8%) did not impact on tumor prognosis. The relationship between ENO1 expression and tumor immunity was analyzed by Tumor Immune Estimation Resource (TIMER) and GEPIA. The potential functions of ENO1 in pathways were investigated by Gene Set Enrichment Analysis. ENO1 expression was significantly different in tumor and corresponding normal tissues. ENO1 expression in multiple tumor tissues correlated with prognosis and stage. ENO1 showed correlation with immune infiltrates including B cells, CD8+ and CD4+ T cells, macrophages, neutrophils, and dendritic cells, and tumor purity. ENO1 was proved to be involved in DNA replication, cell cycle, apoptosis, glycolysis process, and other processes. These findings indicate that ENO1 is a potential prognostic biomarker that correlates with cancer progression immune infiltration.https://www.frontiersin.org/articles/10.3389/fonc.2020.593706/fullEnolase 1 (ENO1)biologic tumor markermutationtumor-infiltratingprognosis
spellingShingle Wenhua Xu
Wenna Yang
Chunfeng Wu
Xiaocong Ma
Haoyu Li
Jinghui Zheng
Enolase 1 Correlated With Cancer Progression and Immune-Infiltrating in Multiple Cancer Types: A Pan-Cancer Analysis
Frontiers in Oncology
Enolase 1 (ENO1)
biologic tumor marker
mutation
tumor-infiltrating
prognosis
title Enolase 1 Correlated With Cancer Progression and Immune-Infiltrating in Multiple Cancer Types: A Pan-Cancer Analysis
title_full Enolase 1 Correlated With Cancer Progression and Immune-Infiltrating in Multiple Cancer Types: A Pan-Cancer Analysis
title_fullStr Enolase 1 Correlated With Cancer Progression and Immune-Infiltrating in Multiple Cancer Types: A Pan-Cancer Analysis
title_full_unstemmed Enolase 1 Correlated With Cancer Progression and Immune-Infiltrating in Multiple Cancer Types: A Pan-Cancer Analysis
title_short Enolase 1 Correlated With Cancer Progression and Immune-Infiltrating in Multiple Cancer Types: A Pan-Cancer Analysis
title_sort enolase 1 correlated with cancer progression and immune infiltrating in multiple cancer types a pan cancer analysis
topic Enolase 1 (ENO1)
biologic tumor marker
mutation
tumor-infiltrating
prognosis
url https://www.frontiersin.org/articles/10.3389/fonc.2020.593706/full
work_keys_str_mv AT wenhuaxu enolase1correlatedwithcancerprogressionandimmuneinfiltratinginmultiplecancertypesapancanceranalysis
AT wennayang enolase1correlatedwithcancerprogressionandimmuneinfiltratinginmultiplecancertypesapancanceranalysis
AT chunfengwu enolase1correlatedwithcancerprogressionandimmuneinfiltratinginmultiplecancertypesapancanceranalysis
AT xiaocongma enolase1correlatedwithcancerprogressionandimmuneinfiltratinginmultiplecancertypesapancanceranalysis
AT haoyuli enolase1correlatedwithcancerprogressionandimmuneinfiltratinginmultiplecancertypesapancanceranalysis
AT jinghuizheng enolase1correlatedwithcancerprogressionandimmuneinfiltratinginmultiplecancertypesapancanceranalysis